Screening guidelines for individuals at increased risk for prostate cancer

Area of Science:

• Oncology
• Genetics
• Public Health

Background:

• Prostate cancer (PCa) risk stratification lacks consistent definitions in current guidelines.
• Existing guidelines from NCCN and AU A offer differing recommendations for screening initiation and methods.

Purpose of the Study:

• To highlight the inconsistencies in defining individuals at increased risk for prostate cancer.
• To emphasize the need for standardized approaches in PCa risk assessment and screening protocols.

Main Methods:

• Review of current national and international guidelines for prostate cancer risk identification.
• Analysis of NCCN and American Urological Association (AU A) screening recommendations.
• Proposal for patient registries to facilitate ongoing research in PCa risk.

Main Results:

• Significant variability exists in defining high-risk populations for prostate cancer.
• Recommendations for screening initiation (e.g., age 40) and methods (PSA, DRE) vary.
• Germline mutations, family history, and ancestry are key factors in PCa risk assessment.

Conclusions:

• Standardizing the definition of increased prostate cancer risk is crucial for equitable screening.
• Patient registries are essential for advancing the understanding of PCa lifetime risk.
• Further research is needed to refine PCa risk stratification and screening strategies.